Clinical Guest Contributors

  1. Diverse Enrollment In Clinical Trials: What Do Successful Research Sites Have In Common? 5/19/2020

    Diverse enrollment in clinical research studies is a complex issue that has multifaceted implications for clinical research sites. An understanding of the research site community’s perceived awareness and current ability to enroll these populations is lacking in the clinical trials landscape.

  2. Move Virtual Trials From Aspiration To Reality In Today’s Environment 5/14/2020

    With the COVID-19 pandemic upon us, we are at a place where the business case is clear, the barriers to adoption are largely removed, and sites and participants alike have begun accepting virtual trials as not just an option but a must.

  3. COVID-19 & Clinical Trials: Understanding The Long-Term Impact 5/12/2020

    While most regulatory agencies have stated an intention to be flexible during these unprecedented times, it is critical that drug developers continue to monitor their risk diligently and develop contingency plans to adapt and respond to factors that affect their clinical development programs.

  4. eConsent In Clinical Trials: Insights For Implementation During COVID-19 And Beyond 5/7/2020

    The world has changed in the wake of COVID-19. To adjust, clinical trial sponsors must adapt their protocols, and many are urgently doing so, to provide virtual tools for clinical trial use. One example of an important tool in this space is electronic consent, or eConsent.

  5. How Do Underserved Communities Prefer To Learn About Clinical Research? 5/5/2020

    It is important to look at the big picture and better understand core participation motivators and barriers from the underrepresented patient’s perspective in order to better enable access to and increase their participation in clinical trials.

  6. Developing A Clinical Trials Strategy For A Post-COVID World 5/4/2020

    It’s becoming clear that we need proactive, collaborative planning and execution to mitigate the impact we’ll absorb when the pandemic loosens its grip on our industry, along with a significant effort to advance our virtual capabilities forward.

  7. Which New Technologies & Training Will Drive Advancements In Clinical Trials? 4/30/2020

    Many changes are taking place that are having an impact on the conduct of clinical trials. New tools such as risk-based monitoring, real-world evidence, and adaptive trials are helping to fix a process that many believe is fundamentally broken. At the same time, trials are becoming more complex and new guidelines are being placed on sponsors. What will all of this mean for the conduct of trials in 2020 and beyond?

  8. Clinical Trials At Home — Implementing Telemedicine & Virtual Visits During COVID-19 4/27/2020

    There is no denying that the COVID-19 pandemic has spurred tremendous — and fast — innovation across our industry. Most importantly, the expansion of telemedicine and virtual solutions is enabling us to meet our patients’ needs while also maintaining patient safety, study integrity, and data quality.

  9. 3 Reasons Why You Should Start Simplifying Your Clinical Trial Agreements 4/23/2020

    Have you ever come across clinical trial agreements that look like walls of text? You struggle through clauses written with multiple negatives within a paragraph or language containing archaisms and technical legal terms that no businessperson will understand. Did you feel “invited” to read on?

  10. How To Accelerate Adoption Of Patient Technology In Clinical Trials 4/21/2020

    Although the benefits of implementing it in clinical studies are evident, patient technology has yet to make a clear entrance into the clinical arena, as many trials continue to rely on traditional research methodology.